Platinum Co-ordination Complexes in Cancer Chemotherapy
نویسنده
چکیده
Following its widespread adoption into clinical practice in the early 1970s the drug cispiatin (cis-diamminedichloroplatinum(II), cis[PrClfiH J2]) has improved substantially the response rate5 in a number of malignant conditions, particularly testicular and ovarian cancer. However, the clinical utility of the drug is limited by its toxic side effects. The most significant of these is kidney toxicity (nephrotoxicity), though in addition cisplatin produces severe nausea and vomiting, high frequency hearing loss and neurotoxicity. In the past decade immense efforts have been devoted to elucidating the molecular mechanism of the action of cisplatin, and its biochemistry and pharmacology, both in animals and man. Because of the toxic restrictions of the drug much attention has been devoted also to identifying analogues which retain cisplatin’s useful anti-tumour properties, but which are so far as possible devoid of its toxic limitations. The international meeting held at the University of Vermont, Burlington, U.S.A. during June 1983 provided a timely opportunity, not only to review current knowledge on the molecular mechanisms of action of platinum complexes and their pharmacological properties, but also to compare data emerging from studies of those derivatives which are undergoing clinical evaluation. Inevitably, limitations of space and the scientific predilections of this reviewer may conspire to create an unintentional imbalance in the report of what proved to be an excellently conceived and highly successful meeting. If this be so, then apologies must be accorded in advance to those scientists whose work may seem to have been overlooked. The reader is referred to Figure I for the structures of platinum complexes discussed and to the end of the article for a list of background references supporting this report. The proceedings of this conference are published by Martinus Nijhoff and full acknowledgement of the contributing authors, which is omitted from this review, can be found therein.
منابع مشابه
Cisplatin in the Treatment of Cancer THE FIRST METAL ANTI - TUMOUR DRUG
A platinum compound, cis-diamminedichloroplatinum (II)-known as cisplatin-has recently received the approval of the governments of the United States of America and the United Kingdom for chemotherapy of specific cancers. This paper gives a brief account of the discovery of the physiological activity of certain platinum co-ordination complexes by Professor Barnett Rosenberg and his colleagues, a...
متن کاملA Survey of Anticancer Effect of Some Five- and Six-Membered Palladium (II) Complexes (Containing Bidentate Phosphorus Ligands) on Caco-2 Colon Cancer Cell Line
Background and Objectives: Transition metal complexes possess a variety of biological and pharmacological activities, such as antitumor, antimicrobial, anti-inflammatory, anti-diabetic, and free radical scavenging. Many studies have been carried out on platinum-based chemotherapy agents, however, most attention has been paid to non-platinum metal-based agents in order to find different metal comp...
متن کاملAnti-tumor activity of Fe (III), Co(II) and Pd(II) complexes of N3-{phenyl [(4-pyridylcarbonyl)amino]methyl}
An anti-tumor compound as N3-{phenyl [(4-pyridylcarbonyl) amino] methyl} weresynthesized and identified (NPPA). Fe (III), Co(II) and Pd(II) metal complexes of this ligand preparedby reaction of chloride salt of Fe (III), Co(II) and Pd(II) with NPPA in dry acetonitrile. Identification andCharacterization of the ligand was performed by FT-IR, 1H-NMR spectroscopy and elemental an...
متن کاملInteractions of platinum metals and their complexes in biological systems.
Platinum-metal oxidation catalysts are to be introduced in exhaust systems of many 1975 model-year automobiles in the U.S. to meet Clean Air Act standards. Small quantities of finely divided catalyst have been found issuing from prototype systems; platinum and palladium compounds may be found also. Although platinum exhibits a remarkable resistance to oxidation and chemical attack, it reacts ch...
متن کاملPt(II) and Pt(IV) complexes with large hydrophobic ligands: a study of new potential cytostatics
Breast cancer is a major health problem among women in the world. The successful treatment of this disease is limited by the fact that essentially all breast cancers become resistant to chemotherapy. Therefore, there is a need to design new chemotherapeutic agents able not only to target breast cancer but also to display increased efficacy and overall decreased systemic toxicity. Platinum (II) ...
متن کامل